|
FXR2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.744800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.472400E-01 |
| Normal-vs-Stage2 |
1.616220E-01 |
| Normal-vs-Stage3 |
7.472400E-01 |
| Normal-vs-Stage4 |
8.156600E-01 |
| Stage1-vs-Stage2 |
2.690400E-01 |
| Stage1-vs-Stage3 |
2.976800E-01 |
| Stage1-vs-Stage4 |
8.280800E-01 |
| Stage2-vs-Stage3 |
6.890400E-02 |
| Stage2-vs-Stage4 |
2.881200E-01 |
| Stage3-vs-Stage4 |
5.857800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.577800E-01 |
| Normal-vs-AfricanAmerican |
2.865700E-02 |
| Normal-vs-Asian |
7.029600E-01 |
| Caucasian-vs-AfricanAmerican |
1.193530E-02 |
| Caucasian-vs-Asian |
8.638600E-01 |
| AfricanAmerican-vs-Asian |
6.316000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.100400E-01 |
| Normal-vs-Female |
3.629400E-01 |
| Male-vs-Female |
1.185560E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.407200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.870000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.886000E-01 |
| Normal-vs-Age(81-100Yrs) |
8.103200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.816800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.696800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.508400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.986000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.018200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.875400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.666390E-01 |
| Classical-VS-Follicular |
3.871200E-01 |
| Classical-VS-Other |
3.260000E-01 |
| Classical-VS-Normal |
3.194000E-01 |
| Tall-VS-Follicular |
5.984600E-01 |
| Tall-VS-Other |
7.728000E-01 |
| Tall-VS-Normal |
5.684200E-01 |
| Follicular-VS-Other |
6.933600E-01 |
| Follicular-VS-Normal |
9.861200E-01 |
| Other-VS-Normal |
5.431800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.415200E-01 |
| Normal-vs-N1 |
2.821800E-01 |
| N0-vs-N1 |
1.621790E-01 |
|
|
